glp-1 release for Weight Loss and Diabetes Current Insights, Advantages and Challenges

Quick Answer: What Should GLP-1 Users Eat When Appetite Is Low

Diabetologia 45 , 11111119 (2002)

These shifts can result in heightened cravings and increased hunger, making it difficult to maintain a calorie deficit

At 48 weeks, participants on the 8 mg dose achieved a mean body weight reduction of 22.8%, while those on the highest 12 mg dose achieved a mean reduction of 24.2% compared to just 2.1% in the placebo group

Neurol Sci (2019) 40(8):152740

Topiramate is not a controlled substance, but it carries its own regulatory requirements, including the REMS (Risk Evaluation and Mitigation Strategy) program that Qsymia must follow due to the risk of birth defects